Sign In
Buy MEDP
$458.69
+7.88 (+1.75%)
At Close: Jun 04, 2026
Medpace (MEDP) Falls More Steeply Than Broader Market: What Investors Need to Know
07:21pm, Monday, 03'rd Feb 2025
In the closing of the recent trading day, Medpace (MEDP) stood at $343.38, denoting a -1.65% change from the preceding trading day.
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud
11:00am, Sunday, 02'nd Feb 2025
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
LOS ANGELES, CA / ACCESS Newswire / February 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud
11:00am, Friday, 31'st Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 31, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
11:00am, Thursday, 30'th Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 30, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
A Quest That Has Translated Into New Investments
11:00pm, Wednesday, 29'th Jan 2025
Focus on companies with proven business models, strong management, and potential for long-term market share growth in large industries. M&T Bank, Ashtead Group, Installed Building Products, Fiserv, Fe
Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
07:20pm, Monday, 27'th Jan 2025
In the latest trading session, Medpace (MEDP) closed at $350.37, marking a +1.83% move from the previous day.
LOS ANGELES, CA / ACCESS Newswire / January 27, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
LOS ANGELES, CA / ACCESS Newswire / January 26, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
MoneyShow's Best Investment Ideas For 2025: Part 6
02:35pm, Friday, 24'th Jan 2025
MoneyShow presents top investment ideas for 2025 from their contributors. This year's edition presents a broad mix of theme-based stock picks, momentum-driven high-flyers and beaten-up stocks with tur
LOS ANGELES, CA / ACCESS Newswire / January 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
11:30am, Thursday, 23'rd Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 23, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Medpace Holdings, Inc. For Securities Law Violations
11:15am, Wednesday, 22'nd Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 22, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm
01:30pm, Tuesday, 21'st Jan 2025
LOS ANGELES, CA / ACCESS Newswire / January 21, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medpace H
